Morpholino

MO2-rac2

ID
ZDB-MRPHLNO-201217-3
Name
MO2-rac2
Previous Names
None
Target
Sequence
5' - GTAACTTTTCACTCACCCATCTCCG - 3'
Disclaimer
Although ZFIN verifies reagent sequence data, we recommend that you conduct independent sequence analysis before ordering any reagent.
Note
Splice-blocking MO.
Genome Resources
None
Target Location
Genomic Features
No data available
Expression
Gene expression in Wild Types + MO2-rac2
No data available
Phenotype
Phenotype resulting from MO2-rac2
No data available
Phenotype of all Fish created by or utilizing MO2-rac2
Phenotype Fish Conditions Figures
leukocyte migration disrupted, abnormal WT + MO1-rac2 + MO2-rac2 standard conditions Fig. 4 from Lu et al., 2020
thymus primordium leukocyte coro1a expression decreased amount, abnormal WT + MO1-rac2 + MO2-rac2 standard conditions Fig. 4 from Lu et al., 2020
thymus lcp1 expression decreased amount, abnormal WT + MO1-rac2 + MO2-rac2 standard conditions Fig. 4 from Lu et al., 2020
caudal hematopoietic tissue pro-T cell myb expression increased amount, abnormal WT + MO1-rac2 + MO2-rac2 standard conditions Fig. 4 from Lu et al., 2020
thymus leukocyte coro1a expression decreased amount, abnormal WT + MO1-rac2 + MO2-rac2 standard conditions Fig. 4 from Lu et al., 2020
caudal hematopoietic tissue pro-T cell irf4a expression increased amount, abnormal WT + MO1-rac2 + MO2-rac2 standard conditions Fig. 4 from Lu et al., 2020
thymus T cell lck expression decreased amount, abnormal WT + MO1-rac2 + MO2-rac2 standard conditions Fig. 2 from Lu et al., 2020
thymus T cell rag1 expression decreased amount, abnormal WT + MO1-rac2 + MO2-rac2 standard conditions Fig. 2 from Lu et al., 2020
caudal hematopoietic tissue pro-T cell ccr9a expression increased amount, abnormal WT + MO1-rac2 + MO2-rac2 standard conditions Fig. 4 from Lu et al., 2020
thymus T cell ccr9a expression decreased amount, abnormal WT + MO1-rac2 + MO2-rac2 standard conditions Fig. 2 from Lu et al., 2020
caudal hematopoietic tissue leukocyte lcp1 expression increased amount, abnormal WT + MO1-rac2 + MO2-rac2 standard conditions Fig. 4 from Lu et al., 2020
thymus T cell ccr9b expression decreased amount, abnormal WT + MO1-rac2 + MO2-rac2 standard conditions Fig. 2 from Lu et al., 2020
thymus leukocyte lcp1 expression decreased amount, abnormal WT + MO1-rac2 + MO2-rac2 standard conditions Fig. 4 from Lu et al., 2020
pro-T cell cell migration disrupted, abnormal WT + MO1-rac2 + MO2-rac2 standard conditions Fig. 4 from Lu et al., 2020
caudal hematopoietic tissue pro-T cell mislocalised, abnormal WT + MO1-rac2 + MO2-rac2 standard conditions Fig. 4 from Lu et al., 2020
caudal hematopoietic tissue leukocyte coro1a expression increased amount, abnormal WT + MO1-rac2 + MO2-rac2 standard conditions Fig. 4 from Lu et al., 2020
caudal hematopoietic tissue leukocyte mislocalised, abnormal WT + MO1-rac2 + MO2-rac2 standard conditions Fig. 4 from Lu et al., 2020
thymus T cell decreased amount, abnormal hkz04tTg + MO1-rac2 + MO2-rac2 standard conditions Fig. 2 from Lu et al., 2020
thymus T cell decreased amount, abnormal zf411Tg + MO1-rac2 + MO2-rac2 standard conditions Fig. 2 from Lu et al., 2020
Citations